Intracellular calcium controls a variety of cellular functions such as contraction, secretion, proliferation, and gene expression. One of the major pathways of calcium influx into cells is through voltage-activated Ca2+ channels. Low voltage-activated, T-type, Ca2+ channels can open after small depolarizations of the plasma membrane, leading to further depolarization of the membrane (pacemaker activity) and changes in intracellular Ca2+. T channels are also thought to play important roles in burst firing and in oscillatory behavior of neurons. Their ability to inactivate and recover quickly over a narrow voltage range are considered key properties of thalamic neurons, allowing them to show distinct firing patterns that correlate with sleep and wakefulness. Many antiepileptic drugs can block these channels in vitro, leading to the hypothesis that abnormal expression of T channels may be involved in epilepsy. Exciting preliminary studies demonstrate the cloning and expression of a new family of alpha1 subunits that encode T-type Ca2+ channels. Cloning of these channels has opened up new areas of research that should identify the physiology of this important class of ion channel.
The specific aims of this project are to: 1) characterize the electrophysiological properties of these cloned T-type channels; 2) characterize their pharmacology, in particular their block by divalent cations, antihypertensives, and antiepileptics; 3) investigate structure-function relationships of T-type channels, focusing on inactivation properties; and 4) investigate the subunit structure of these channels, focusing on how Ca channels are regulated by their beta subunits. The research design uses recombinant DNA techniques to clone and modify T-type channels and express the cloned channels in both Xenopus laevis oocytes and HEK-293 cells. Electrophysiological methods are used to study the expressed channel at both the single channel and whole cell level. These studies should provide significant insights into the functional diversity of voltage-activated Ca channels, their pharmacology, and how their structure determines their function in neuronal signaling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS038691-04
Application #
6394134
Study Section
Special Emphasis Panel (ZRG1-MDCN-4 (01))
Program Officer
Stewart, Randall
Project Start
1999-07-05
Project End
2004-05-31
Budget Start
2001-06-01
Budget End
2002-05-31
Support Year
4
Fiscal Year
2001
Total Cost
$321,458
Indirect Cost
Name
University of Virginia
Department
Pharmacology
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Perez-Reyes, Edward; Lee, Jung-Ha (2014) Ins and outs of T-channel structure function. Pflugers Arch 466:627-33
Perez-Reyes, Edward (2010) Characterization of the gating brake in the I-II loop of CaV3 T-type calcium channels. Channels (Austin) 4:453-8
Strege, Peter R; Sha, Lei; Beyder, Arthur et al. (2010) T-type Ca(2+) channel modulation by otilonium bromide. Am J Physiol Gastrointest Liver Physiol 298:G706-13
Perez-Reyes, Edward; Van Deusen, Amy L; Vitko, Iuliia (2009) Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther 328:621-7
Arias-Olguin, Imilla I; Vitko, Iuliia; Fortuna, Michal et al. (2008) Characterization of the gating brake in the I-II loop of Ca(v)3.2 T-type Ca(2+) channels. J Biol Chem 283:8136-44
Shcheglovitov, Aleksandr; Vitko, Iuliia; Bidaud, Isabelle et al. (2008) Alternative splicing within the I-II loop controls surface expression of T-type Ca(v)3.1 calcium channels. FEBS Lett 582:3765-70
Nelson, Michael T; Joksovic, Pavle M; Su, Peihan et al. (2007) Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate. J Neurosci 27:12577-83
Xie, Xinmin; Van Deusen, Amy L; Vitko, Iuliia et al. (2007) Validation of high throughput screening assays against three subtypes of Ca(v)3 T-type channels using molecular and pharmacologic approaches. Assay Drug Dev Technol 5:191-203
Vitko, Iuliia; Bidaud, Isabelle; Arias, Juan Manuel et al. (2007) The I-II loop controls plasma membrane expression and gating of Ca(v)3.2 T-type Ca2+ channels: a paradigm for childhood absence epilepsy mutations. J Neurosci 27:322-30
Nelson, Michael T; Woo, Jiwan; Kang, Ho-Won et al. (2007) Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels. J Neurosci 27:8250-60

Showing the most recent 10 out of 29 publications